Artificial intelligence has worked its way into numerous business sectors under the guise of improving efficiency, but in the medical field it promises to do even more: save lives.
AI Medical Service, a Tokyo-based startup developing an AI-based endoscopic diagnostic support system, is convinced of the technology’s capabilities and aims to prove its effectiveness.
Gastrointestinal cancers are a major cause of cancer death worldwide — they account for 1 in 3 such deaths globally — and the startup says this is largely due to an inability to detect them at an early stage.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.